Dr. Graeme M. Lipper, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- Harvard Medical School (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,272
Licensed in Connecticut since 2002, according to the Connecticut Department of Public Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: Harvard Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
CT license 040494 (first issued 2002; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Danbury Hospital Danbury, CT
Medical groups
- Advanced Dermcare PC (10 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,272
- Services billed
- 5,736
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 1,840 | 385 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,178 | 904 |
| Destruction of precancer skin growth, 1 growth | 715 | 562 |
| Biopsy of related skin growth, first growth | 427 | 379 |
| Established patient office or other outpatient visit, 30-39 minutes | 314 | 264 |
| Destruction of skin growth, 1-14 growths | 119 | 114 |
| New patient office or other outpatient visit, 30-44 minutes | 116 | 116 |
| Application of ultraviolet light to skin | 94 | 15 |
| Biopsy of related skin growth, each additional growth | 85 | 65 |
| Established patient office or other outpatient visit, 10-19 minutes | 68 | 66 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Mupirocin Other prescribers in Danbury, CT | 337 |
| Ketoconazole Other prescribers in Danbury, CT | 335 |
| Ciclopirox (ciclopirox olamine) | 228 |
| Triamcinolone Acetonide Other prescribers in Danbury, CT | 143 |
| Metronidazole Other prescribers in Danbury, CT | 113 |
| Clobetasol Propionate Other prescribers in Danbury, CT | 97 |
| Betamethasone Diprop Augmented (betamethasone/propylene glyc) | 94 |
| Ciclopirox Other prescribers in Danbury, CT | 83 |
| Fluorouracil Other prescribers in Danbury, CT | 61 |
| Valacyclovir (valacyclovir hcl) Other prescribers in Danbury, CT | 58 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 75 payments worth $1,935 in total to this clinician.
| AbbVie Inc. | $473 |
|---|---|
| Leo Pharma Inc. | $225 |
| Galderma Laboratories, L.P. | $211 |
| Genzyme Corporation | $181 |
| Janssen Biotech, Inc. | $173 |
| Incyte Corporation | $145 |
| Pfizer Inc. | $81.11 |
| UCB, Inc. | $74.68 |
| Food and Beverage | $1,846 |
|---|---|
| Education | $89.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Apr 4, 2025 | Education TREMFYA · Immunology · in-kind | $89.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.